| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $392.9M | — | +28.2% |
| Cost of Revenue | $61.6M | — | +25.2% |
| R&D Expense | $103.3M | — | +43.9% |
| SG&A Expense | $264.6M | — | +54.1% |
| Operating Income | -$48.3M | — | -450.1% |
| Pre-tax Income | -$61.9M | — | -343.0% |
| Income Tax | $4.6M | — | +50.5% |
| Net Income | -$66.5M | — | -395.9% |
| EPS (Basic) | -$0.40 | — | -385.7% |
| EPS (Diluted) | -$0.40 | — | -407.7% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $351.6M | -9.5% | -12.1% |
| Accounts Receivable | $407.6M | +22.0% | +27.9% |
| Inventory | $336.7M | +71.2% | +83.6% |
| Current Assets | $1.36B | -29.6% | -8.1% |
| Total Assets | $4.26B | +71.2% | +104.5% |
| Current Liabilities | $599.5M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$165.7M | — | -267.7% |
| Capital Expenditures | $4.1M | — | -59.5% |
| Investing Cash Flow | -$2.08B | — | — |
| Financing Cash Flow | $1.47B | — | — |
| Free Cash Flow | -$169.8M | — | -291.5% |
| +35.1% |
| Long-term Debt | $1.52B | — | — |
| Total Liabilities | $2.51B | +275.4% | +339.4% |
| Stockholders' Equity | $1.75B | -3.7% | +15.9% |